Valuation: Ipca Laboratories Limited

Market Cap 440B 4.63B 4B 3.74B 3.43B 6.45B 6.55B 43.82B 17.19B 221B 17.37B 16.99B 730B P/E 2027 *
31.6x
P/E 2028 * 26.5x
Enterprise Value 429B 4.5B 3.9B 3.64B 3.34B 6.28B 6.37B 42.65B 16.73B 215B 16.9B 16.53B 710B EV / Sales 2027 *
3.98x
EV / Sales 2028 * 3.47x
Free-Float
54.94%
Yield 2027 *
0.33%
Yield 2028 * 0.36%
1 day+0.20%
1 week-0.59%
Current month-0.59%
1 month-1.37%
3 months+11.93%
6 months+21.95%
Current year+21.97%
1 week 1,645.9
Extreme 1645.9
1,783.8
1 month 1,645.9
Extreme 1645.9
1,941.4
Current year 1,392
Extreme 1392
1,941.4
1 year 1,252.95
Extreme 1252.95
1,941.4
3 years 849.25
Extreme 849.25
1,941.4
5 years 670
Extreme 670
1,941.4
10 years 200
Extreme 200
1,941.4
Manager TitleAgeSince
Chief Executive Officer 53 2023-03-31
Chief Executive Officer 70 2023-03-31
Chief Tech/Sci/R&D Officer 52 2023-10-15
Director TitleAgeSince
Chairman 79 2012-07-04
Director/Board Member 53 2008-11-10
Director/Board Member 70 1994-07-31
Change 5-day change 1-year change 3-year change Capi.($)
+0.20%-0.59% - - 4.63B
-0.52%+3.21%+89.52%+127.32% 1,057B
+0.88%+1.13%+49.56%+49.69% 625B
+0.89%-1.95%+24.23%+64.44% 435B
+0.71%+3.87%+49.07%+37.85% 363B
+0.64%-0.49%+33.94%+40.01% 296B
+0.39%-5.83%+8.92%+7.85% 249B
+1.51%+6.69%+42.58%+57.57% 222B
+3.92%-0.46%-5.56%-52.32% 209B
+1.80%+2.30%+11.56%+66.35% 165B
Average +1.04%+0.87%+33.76%+44.31% 402.31B
Weighted average by Cap. +0.66%+1.22%+48.72%+64.63%

Financials

2027 *2028 *
Net sales 108B 1.13B 979M 914M 839M 1.58B 1.6B 10.72B 4.2B 53.93B 4.25B 4.15B 179B 120B 1.26B 1.09B 1.02B 935M 1.76B 1.79B 11.95B 4.69B 60.13B 4.74B 4.63B 199B
Net income 14B 147M 127M 119M 109M 205M 208M 1.39B 546M 7.01B 552M 540M 23.21B 16.7B 175M 152M 142M 130M 244M 248M 1.66B 652M 8.36B 659M 644M 27.68B
Net Debt -11.82B -124M -107M -100M -92.09M -173M -176M -1.18B -461M -5.92B -466M -456M -19.6B -23.66B -249M -215M -201M -184M -346M -352M -2.35B -923M -11.85B -933M -913M -39.22B
Logo Ipca Laboratories Limited
Ipca Laboratories Limited is an India-based integrated pharmaceutical company. The Company is engaged in manufacturing and marketing over 350 formulations and approximately 80 active pharmaceutical ingredients (APIs) covering various therapeutic segments. It offers APIs, such as Atenolol, Chloroquine Phosphate, Chlorthalidone, Furosemide, Hydroxychloroquine sulfate, Losartan, Metoprolol Succinate, Metoprolol Tartrate, Pyrantel Salts and Propranolol. The Company offers brands, such as Zerodol, Lariago, HCQS, Perinorm, Rapither AB, Tenoric, Lumerax, Etova, Fexova, Malirid, Allsuth, Alwiz, AZR 50mg, Bacilon, Cinkona, Clarbact, Glyree MV, Halotop, Luliz, Ozepam, Pacimol, Pari, Xtor-F, Zabpro, Zilast, Ramcor, Sove, Venpower and Folitrax. The Company’s products are sold in over 100 countries across the globe. The Company has 18 manufacturing units in India manufacturing APIs and formulations. Its subsidiaries include Ipca Pharmaceuticals, Inc. and Ipca Pharma Nigeria Ltd.
Employees
17,210
Date Price Change Volume
26-08-07 ₹1,736.85 +0.20% 5,314
26-08-06 ₹1,733.45 -1.89% 13,966
26-08-05 ₹1,766.85 +5.03% 11,991
26-08-04 ₹1,682.25 -2.38% 74,803
26-08-03 ₹1,723.25 -1.37% 12,083
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
1,735.80INR
Average target price
1,733.50INR
Spread / Average Target
-0.13%

Quarterly revenue - Rate of surprise